跳至主要内容
临床试验/NCT02018991
NCT02018991已完成4 期

Incidence and Predictors for Late Acquired Stent Malaposition of Drug-Eluting-Stents With Second-Generation Permanent and Biodegradable Polymer-Coatings - a Prospective, Randomized Comparison Using Optical Coherence Tomography

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
69
试验地点
2
主要终点
Number of stent struts with late acquired malaposition

研究概览

简要总结

The polymers releasing the drug of first-generation drug-eluting stents (DES) may induce allergic reactions and inflammation, resulting in late-acquired stent malaposition (LASM) with uncoverage of struts, and risk of stent thrombosis. The incidence and predictors of LASM in DES with newer-generation polymers designed to improve biocompatibility are unknown.

详细描述

please see brief summary

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who underwent an elective treatment of a coronary lesion > 20mm with a DES

排除标准

  • chronic renal failure (serum creatinine ≥ 2.5mg/dl)
  • restenotic lesions

结局指标

主要结局

Number of stent struts with late acquired malaposition

时间窗: 1 year after stent implantation

次要结局

  • number of stent struts with late acquired malaposition(2 years after stent implantation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Univ. Prof. Dr. Thomas Neunteufl

Univ. Prof. Dr.

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验